CareDx Return on Tangible Equity 2013-2023 | CDNA
CareDx Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2023-12-31 | $-0.19B | $0.18B | -66.73% |
2023-09-30 | $-0.09B | $0.31B | -27.40% |
2023-06-30 | $-0.08B | $0.32B | -24.67% |
2023-03-31 | $-0.08B | $0.34B | -23.14% |
2022-12-31 | $-0.08B | $0.35B | -21.43% |
2022-09-30 | $-0.08B | $0.36B | -20.46% |
2022-06-30 | $-0.07B | $0.36B | -18.56% |
2022-03-31 | $-0.05B | $0.37B | -12.87% |
2021-12-31 | $-0.03B | $0.38B | -7.84% |
2021-09-30 | $-0.02B | $0.40B | -5.38% |
2021-06-30 | $-0.01B | $0.41B | -3.29% |
2021-03-31 | $-0.02B | $0.40B | -5.98% |
2020-12-31 | $-0.02B | $0.21B | -12.56% |
2020-09-30 | $-0.02B | $0.20B | -18.34% |
2020-06-30 | $-0.02B | $0.19B | -28.07% |
2020-03-31 | $-0.02B | $0.03B | -71.79% |
2019-12-31 | $-0.02B | $0.03B | -68.15% |
2019-09-30 | $-0.02B | $0.03B | -56.41% |
2019-06-30 | $-0.04B | $0.03B | -100.00% |
2019-03-31 | $-0.05B | $0.05B | -157.26% |
2018-12-31 | $-0.05B | $0.05B | -348.15% |
2018-09-30 | $-0.08B | $0.03B | 625.00% |
2018-06-30 | $-0.07B | $-0.02B | 219.05% |
2018-03-31 | $-0.06B | $-0.01B | 166.20% |
2017-12-31 | $-0.06B | $-0.05B | 139.13% |
2017-09-30 | $-0.04B | $-0.05B | 113.87% |
2017-06-30 | $-0.03B | $-0.03B | 98.31% |
2017-03-31 | $-0.04B | $-0.03B | 120.69% |
2016-12-31 | $-0.04B | $-0.03B | 185.71% |
2016-09-30 | $-0.03B | $-0.03B | 252.17% |
2016-06-30 | $-0.03B | $-0.03B | 2800.00% |
2016-03-31 | $-0.02B | $0.00B | -182.61% |
2015-12-31 | $-0.01B | $0.01B | -80.00% |
2015-09-30 | $-0.01B | $0.02B | -41.56% |
2015-06-30 | $-0.00B | $0.02B | -19.05% |
2015-03-31 | $0.00B | $0.02B | 0.00% |
2014-12-31 | $0.00B | $0.02B | 50.00% |
2014-09-30 | $0.00B | $0.02B | 0.00% |
2014-06-30 | $-0.00B | $-0.02B | 15.38% |
2014-03-31 | $-0.00B | $-0.02B | 50.00% |
2013-12-31 | $-0.00B | $-0.02B | 106.67% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.503B | $0.280B |
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $122.475B | 15.37 |
Cencora (COR) | United States | $44.674B | 17.41 |
ICON (ICLR) | Ireland | $25.493B | 24.07 |
DiDi Global (DIDIY) | China | $24.448B | 0.00 |
Avantor (AVTR) | United States | $16.791B | 24.72 |
Viatris (VTRS) | United States | $14.026B | 4.03 |
CochLear (CHEOY) | Australia | $13.917B | 0.00 |
Revvity (RVTY) | United States | $12.428B | 21.78 |
Medpace Holdings (MEDP) | United States | $12.163B | 40.02 |
Charles River Laboratories (CRL) | United States | $12.026B | 21.92 |
Natera (NTRA) | United States | $11.711B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.540B | 0.00 |
Solventum (SOLV) | United States | $11.153B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.297B | 0.00 |
HealthEquity (HQY) | United States | $6.740B | 50.35 |
Organon (OGN) | United States | $5.043B | 4.78 |
Bausch + Lomb (BLCO) | Canada | $4.779B | 19.16 |
Doximity (DOCS) | United States | $4.494B | 33.46 |
PACS (PACS) | United States | $3.725B | 0.00 |
Sotera Health (SHC) | United States | $3.119B | 15.31 |
Surgery Partners (SGRY) | United States | $3.118B | 28.86 |
Progyny (PGNY) | United States | $3.049B | 51.16 |
GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
Life Times (LTH) | United States | $2.783B | 29.48 |
Premier (PINC) | United States | $2.460B | 9.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.256B | 7.30 |
Teladoc Health (TDOC) | United States | $2.167B | 0.00 |
Agilon Health (AGL) | United States | $1.985B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.970B | 0.00 |
NovoCure (NVCR) | Jersey | $1.590B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.451B | 0.00 | |
Agiliti (AGTI) | United States | $1.374B | 22.44 |
Alignment Healthcare (ALHC) | United States | $1.268B | 0.00 |
Pediatrix Medical (MD) | United States | $0.784B | 8.11 |
Embecta (EMBC) | United States | $0.584B | 3.86 |
InnovAge Holding (INNV) | United States | $0.549B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.514B | 0.00 |
LifeMD (LFMD) | United States | $0.512B | 0.00 |
Enhabit (EHAB) | United States | $0.511B | 46.27 |
Auna S.A (AUNA) | Luxembourg | $0.480B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
MultiPlan (MPLN) | United States | $0.422B | 0.00 |
Beauty Health (SKIN) | United States | $0.415B | 0.00 |
ModivCare (MODV) | United States | $0.383B | 7.18 |
DocGo (DCGO) | United States | $0.376B | 60.17 |
Sera Prognostics (SERA) | United States | $0.352B | 0.00 |
Sharecare (SHCR) | United States | $0.270B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
Biodesix (BDSX) | United States | $0.161B | 0.00 |
So-Young (SY) | China | $0.128B | 43.00 |
Oncology Institute (TOI) | United States | $0.080B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.051B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
Nutex Health (NUTX) | United States | $0.034B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
OncoCyte (OCX) | United States | $0.022B | 0.00 |
DermTech (DMTK) | United States | $0.022B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |